Bio-Rad Reports First-Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Bio-Rad Labs (BIO) Tops Q1 EPS by $1.54
April 28, 2022 4:21 PM EDTBio-Rad Labs (NYSE: BIO) reported Q1 EPS of $4.94, $1.54 better than the analyst estimate of $3.40. Revenue for the quarter came in at $700 million versus the consensus estimate of $675.1 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
... More


